- Home
- QLGN vs UOKA Comparison
QLGN vs UOKA Comparison
Compare QLGN & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- UOKA
- Stock Information
- Founded
- QLGN 1996
- UOKA 2002
- Country
- QLGN United States
- UOKA United Kingdom
- Employees
- QLGN N/A
- UOKA N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- UOKA
- Sector
- QLGN Health Care
- UOKA
- Exchange
- QLGN Nasdaq
- UOKA NYSE
- Market Cap
- QLGN 2.8M
- UOKA 2.7M
- IPO Year
- QLGN N/A
- UOKA N/A
- Fundamental
- Price
- QLGN $3.54
- UOKA $2.40
- Analyst Decision
- QLGN
- UOKA
- Analyst Count
- QLGN 0
- UOKA 0
- Target Price
- QLGN N/A
- UOKA N/A
- AVG Volume (30 Days)
- QLGN 9.1K
- UOKA 128.0K
- Earning Date
- QLGN 08-13-2025
- UOKA 08-16-2025
- Dividend Yield
- QLGN N/A
- UOKA N/A
- EPS Growth
- QLGN N/A
- UOKA N/A
- EPS
- QLGN N/A
- UOKA N/A
- Revenue
- QLGN N/A
- UOKA $48,375.00
- Revenue This Year
- QLGN N/A
- UOKA N/A
- Revenue Next Year
- QLGN N/A
- UOKA N/A
- P/E Ratio
- QLGN N/A
- UOKA N/A
- Revenue Growth
- QLGN N/A
- UOKA N/A
- 52 Week Low
- QLGN $2.85
- UOKA $1.98
- 52 Week High
- QLGN $29.44
- UOKA $42.50
- Technical
- Relative Strength Index (RSI)
- QLGN 44.87
- UOKA N/A
- Support Level
- QLGN $3.37
- UOKA N/A
- Resistance Level
- QLGN $3.85
- UOKA N/A
- Average True Range (ATR)
- QLGN 0.23
- UOKA 0.00
- MACD
- QLGN -0.03
- UOKA 0.00
- Stochastic Oscillator
- QLGN 34.29
- UOKA 0.00
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About UOKA MDJM LTD
MDJM Ltd is engaged in providing real estate agency services to its real estate developer clients, and provides, on an as-needed basis, real estate consulting services and independent training services. The company generates all of its revenue from Hotel income. The company derives a majority of its revenue from the United Kingdom.